National Institute of Allergy and Infectious Diseases; Notice of Meetings, 76475-76477 [2010-30810]

Download as PDF jlentini on DSKJ8SOYB1PROD with NOTICES Federal Register / Vol. 75, No. 235 / Wednesday, December 8, 2010 / Notices Boulevard, Bethesda, MD 20892–8401. (301) 435–1439. lf33c.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel N43DA– 11–5564: Developing, Validating, Refining Tools for Ecologic Momentary Assessment. Date: January 6, 2011. Time: 10 a.m. to 12 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call). Contact Person: Kristen V. Huntley, PhD, Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401. (301) 435–1433. huntleyk@mail.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Development of a Device for Autoadministering Naloxone to Overcome Overdose (2223). Date: January 7, 2011. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call). Contact Person: Minna Liang, PhD, Scientific Review Officer, Training and Special Projects Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401. (301) 435–1432. liangm@nida.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Confirming Compliance with Experimental Pharmacotherapy Treatment of Drug Abuse (2225). Date: January 11, 2011. Time: 9:30 a.m. to 12 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call). Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401. (301) 435–1439. lf33c.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel New Techniques for the Large Scale Production and Purification of Antibodies or Vaccines for the Treatment of Substance Use Disorders (8898). Date: January 11, 2011. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate contract proposals. VerDate Mar<15>2010 18:23 Dec 07, 2010 Jkt 223001 Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call). Contact Person: Minna Liang, PhD, Scientific Review Officer, Training and Special Projects Review Branch, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401. (301) 435–1432. liangm@nida.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Tool Development for New or Improved Capture Reagents (7779). Date: January 11, 2011. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call). Contact Person: Jose F. Ruiz, PhD, Scientific Review Administrator, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401. (301) 451–3086. ruizjf@nida.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Realtime Activity as a Potential Diagnostic Marker for Pain or Drug-craving (4413). Date: January 12, 2011. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call). Contact Person: Scott A. Chen, PhD, Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401. (301) 443–9511. chensc@mail.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Improving Measures of Addiction Risk (5562). Date: January 13, 2011. Time: 9:30 a.m. to 1:00 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call). Contact Person: Lyle Furr, Contract Review Specialist, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401. (301) 435–1439. lf33c.nih.gov. Name of Committee: National Institute on Drug Abuse Special Emphasis Panel Development of a Device to Assess Hyperalgesia at the Bed Side by the Cold Pressor (2224). Date: January 13, 2011. Time: 1 p.m. to 4 p.m. PO 00000 Frm 00083 Fmt 4703 Sfmt 4703 76475 Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852. (Telephone Conference Call). Contact Person: Scott A. Chen, PhD, Scientific Review Officer, Office of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892–8401. (301) 443–9511. chensc@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug Abuse and Addiction Research Programs, National Institutes of Health, HHS) Dated: December 2, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–30813 Filed 12–7–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the National Advisory Allergy and Infectious Diseases Council. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Allergy and Infectious Diseases Council. Date: February 7, 2011. Open: 10:30 a.m. to 11:40 a.m. Agenda: Report from the Institute Director. Place: National Institutes of Health, Natcher Building, 45 Center Drive, E:\FR\FM\08DEN1.SGM 08DEN1 jlentini on DSKJ8SOYB1PROD with NOTICES 76476 Federal Register / Vol. 75, No. 235 / Wednesday, December 8, 2010 / Notices Conference Rooms E1/E2, Bethesda, MD 20892. Closed: 11:40 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892. Contact Person: Marvin R. Kalt, PhD, Director, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7610, Bethesda, MD 20892–7610, 301–496–7291, kaltmr@niaid.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council; Acquired Immunodeficiency Syndrome Subcommittee. Date: February 7, 2011. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room A, Bethesda, MD 20892. Open: 1 p.m. to adjournment. Agenda: Program advisory discussions and reports from division staff. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892. Contact Person: Marvin R. Kalt, PhD, Director, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7610, Bethesda, MD 20892–7610, 301–496–7291, kaltmr@niaid.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council; Microbiology and Infectious Diseases Subcommittee. Date: February 7, 2011. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms F1/F2, Bethesda, MD 20892. Open: 1 p.m. to adjournment. Agenda: Reports from the Division Director and other staff. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms F1/F2, Bethesda, MD 20892. Contact Person: Marvin R. Kalt, PhD, Director, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7610, Bethesda, MD 20892–7610, 301–496–7291, kaltmr@niaid.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council; Allergy, Immunology and Transplantation Subcommittee. Date: February 7, 2011. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms F1/F2, Bethesda, MD 20892. Open: 1 p.m. to adjournment. VerDate Mar<15>2010 18:23 Dec 07, 2010 Jkt 223001 Agenda: Reports from the Division Director and other staff. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms F1/F2, Bethesda, MD 20892. Contact Person: Marvin R. Kalt, PhD, Director, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7610, Bethesda, MD 20892–7610, 301–496–7291, kaltmr@niaid.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council Allergy, Immunology and Transplantation Subcommittee. Date: February 7, 2011. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room D, Bethesda, MD 20892. Open: 1 p.m. to adjournment. Agenda: Reports from the Division Director and other staff. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room D, Bethesda, MD 20892. Contact Person: Marvin R. Kalt, PhD, Director, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7610, Bethesda, MD 20892–7610, 301–496–7291, kaltmr@niaid.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council; Acquired Immunodeficiency Syndrome Subcommittee. Date: May 23, 2011. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room A, Bethesda, MD 20892. Open: 1 p.m. to adjournment. Agenda: Program advisory discussions and reports from division staff. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892. Contact Person: Marvin R. Kalt, PhD, Director, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7610, Bethesda, MD 20892–7610, 301–496–7291, kaltmr@niaid.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council; Microbiology and Infectious Diseases Subcommittee. Date: May 23, 2011. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms F1/F2, Bethesda, MD 20892. Open: 1 p.m. to adjournment. Agenda: Reports from the Division Director and other staff. Place: National Institutes of Health, Natcher Building, 45 Center Drive, PO 00000 Frm 00084 Fmt 4703 Sfmt 4703 Conference Rooms F1/F2, Bethesda, MD 20892. Contact Person: Marvin R. Kalt, PhD, Director, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7610, Bethesda, MD 20892–7610, 301–496–7291, kaltmr@niaid.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council; Allergy, Immunology and Transplantation Subcommittee. Date: May 23, 2011. Closed: 8:30 a.m. to 10:15 a.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room D, Bethesda, MD 20892. Open: 1 p.m. to adjournment. Agenda: Reports from the Division Director and other staff. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Room D, Bethesda, MD 20892. Contact Person: Marvin R. Kalt, PhD, Director, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7610, Bethesda, MD 20892–7610, 301–496–7291, kaltmr@niaid.nih.gov. Name of Committee: National Advisory Allergy and Infectious Diseases Council. Date: May 23, 2011. Open: 10:30 a.m. to 11:40 a.m. Agenda: Report from the Institute Director. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892, Closed: 11:40 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892. Contact Person: Marvin R. Kalt, PhD, Director, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7610, Bethesda, MD 20892–7610, 301–496–7291, kaltmr@niaid.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// www.niaid.nih.gov/facts/facts.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, E:\FR\FM\08DEN1.SGM 08DEN1 Federal Register / Vol. 75, No. 235 / Wednesday, December 8, 2010 / Notices and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: December 2, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. National Institutes of Health [FR Doc. 2010–30810 Filed 12–7–10; 8:45 am] Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, December 28, 2010, 8 a.m. to December 29, 2010, 5 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 which was published in the Federal Register on November 29, 2010, 75 FR 73114–73115. The meeting will be held January 6, 2011 to January 7, 2011. The meeting time and location remain the same. The meeting is closed to the public. Center for Scientific Review; Amended Notice of Meeting BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting jlentini on DSKJ8SOYB1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel MBRS Score Grant Applications Review. Date: December 21, 2010. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Room 3AN18, Bethesda, MD 20892. (Telephone Conference Call). Contact: Lisa Dunbar, PhD, Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3AN12, Bethesda, MD 20892. 301–594–2849. dunbarl@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS) Dated: December 2, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–30825 Filed 12–7–10; 8:45 am] BILLING CODE 4140–01–P VerDate Mar<15>2010 18:23 Dec 07, 2010 Jkt 223001 76477 This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: December 2, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–30821 Filed 12–7–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: December 2, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. National Institutes of Health [FR Doc. 2010–30823 Filed 12–7–10; 8:45 am] Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflicts: CIMG and GMPB. Date: December 21, 2010. Time: 12 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Patricia Greenwel, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2178, MSC 7818, Bethesda, MD 20892, 301–435– 1169. greenwep@csr.nih.gov. PO 00000 Frm 00085 Fmt 4703 Sfmt 4703 Center for Scientific Review; Notice of Closed Meeting Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Auditory and Vestibular Neuroscience. Date: December 13, 2010. Time: 1 p.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call) Contact Person: John Bishop, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408– 9664, bishopj@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) E:\FR\FM\08DEN1.SGM 08DEN1

Agencies

[Federal Register Volume 75, Number 235 (Wednesday, December 8, 2010)]
[Notices]
[Pages 76475-76477]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-30810]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of meetings of the 
National Advisory Allergy and Infectious Diseases Council.
    The meetings will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council.
    Date: February 7, 2011.
    Open: 10:30 a.m. to 11:40 a.m.
    Agenda: Report from the Institute Director.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive,

[[Page 76476]]

Conference Rooms E1/E2, Bethesda, MD 20892.
    Closed: 11:40 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Bethesda, MD 20892.
    Contact Person: Marvin R. Kalt, PhD, Director, Division of 
Extramural Activities, National Institutes of Health/NIAID, 6700B 
Rockledge Drive, MSC 7610, Bethesda, MD 20892-7610, 301-496-7291, 
kaltmr@niaid.nih.gov.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council; Acquired Immunodeficiency Syndrome Subcommittee.
    Date: February 7, 2011.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Room A, Bethesda, MD 20892.
    Open: 1 p.m. to adjournment.
    Agenda: Program advisory discussions and reports from division 
staff.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892.
    Contact Person: Marvin R. Kalt, PhD, Director, Division of 
Extramural Activities, National Institutes of Health/NIAID, 6700B 
Rockledge Drive, MSC 7610, Bethesda, MD 20892-7610, 301-496-7291, 
kaltmr@niaid.nih.gov.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council; Microbiology and Infectious Diseases Subcommittee.
    Date: February 7, 2011.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Rooms F1/F2, Bethesda, MD 20892.
    Open: 1 p.m. to adjournment.
    Agenda: Reports from the Division Director and other staff.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Rooms F1/F2, Bethesda, MD 20892.
    Contact Person: Marvin R. Kalt, PhD, Director, Division of 
Extramural Activities, National Institutes of Health/NIAID, 6700B 
Rockledge Drive, MSC 7610, Bethesda, MD 20892-7610, 301-496-7291, 
kaltmr@niaid.nih.gov.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council; Allergy, Immunology and Transplantation 
Subcommittee.
    Date: February 7, 2011.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Rooms F1/F2, Bethesda, MD 20892.
    Open: 1 p.m. to adjournment.
    Agenda: Reports from the Division Director and other staff.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Rooms F1/F2, Bethesda, MD 20892.
    Contact Person: Marvin R. Kalt, PhD, Director, Division of 
Extramural Activities, National Institutes of Health/NIAID, 6700B 
Rockledge Drive, MSC 7610, Bethesda, MD 20892-7610, 301-496-7291, 
kaltmr@niaid.nih.gov.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council Allergy, Immunology and Transplantation 
Subcommittee.
    Date: February 7, 2011.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Room D, Bethesda, MD 20892.
    Open: 1 p.m. to adjournment.
    Agenda: Reports from the Division Director and other staff.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Room D, Bethesda, MD 20892.
    Contact Person: Marvin R. Kalt, PhD, Director, Division of 
Extramural Activities, National Institutes of Health/NIAID, 6700B 
Rockledge Drive, MSC 7610, Bethesda, MD 20892-7610, 301-496-7291, 
kaltmr@niaid.nih.gov.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council; Acquired Immunodeficiency Syndrome Subcommittee.
    Date: May 23, 2011.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Room A, Bethesda, MD 20892.
    Open: 1 p.m. to adjournment.
    Agenda: Program advisory discussions and reports from division 
staff.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892.
    Contact Person: Marvin R. Kalt, PhD, Director, Division of 
Extramural Activities, National Institutes of Health/NIAID, 6700B 
Rockledge Drive, MSC 7610, Bethesda, MD 20892-7610, 301-496-7291, 
kaltmr@niaid.nih.gov.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council; Microbiology and Infectious Diseases Subcommittee.
    Date: May 23, 2011.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Rooms F1/F2, Bethesda, MD 20892.
    Open: 1 p.m. to adjournment.
    Agenda: Reports from the Division Director and other staff.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Rooms F1/F2, Bethesda, MD 20892.
    Contact Person: Marvin R. Kalt, PhD, Director, Division of 
Extramural Activities, National Institutes of Health/NIAID, 6700B 
Rockledge Drive, MSC 7610, Bethesda, MD 20892-7610, 301-496-7291, 
kaltmr@niaid.nih.gov.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council; Allergy, Immunology and Transplantation 
Subcommittee.
    Date: May 23, 2011.
    Closed: 8:30 a.m. to 10:15 a.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Room D, Bethesda, MD 20892.
    Open: 1 p.m. to adjournment.
    Agenda: Reports from the Division Director and other staff.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Room D, Bethesda, MD 20892.
    Contact Person: Marvin R. Kalt, PhD, Director, Division of 
Extramural Activities, National Institutes of Health/NIAID, 6700B 
Rockledge Drive, MSC 7610, Bethesda, MD 20892-7610, 301-496-7291, 
kaltmr@niaid.nih.gov.

    Name of Committee: National Advisory Allergy and Infectious 
Diseases Council.
    Date: May 23, 2011.
    Open: 10:30 a.m. to 11:40 a.m.
    Agenda: Report from the Institute Director.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892,
    Closed: 11:40 a.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Conference Rooms E1/E2, Bethesda, MD 20892.
    Contact Person: Marvin R. Kalt, PhD, Director, Division of 
Extramural Activities, National Institutes of Health/NIAID, 6700B 
Rockledge Drive, MSC 7610, Bethesda, MD 20892-7610, 301-496-7291, 
kaltmr@niaid.nih.gov.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit. Information is also available on the Institute's/Center's 
home page: https://www.niaid.nih.gov/facts/facts.htm, where an agenda 
and any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology,

[[Page 76477]]

and Transplantation Research; 93.856, Microbiology and Infectious 
Diseases Research, National Institutes of Health, HHS)

    Dated: December 2, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-30810 Filed 12-7-10; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.